TOMORROW’SCURE

Have you ever wondered how artificial intelligence is helping solve medical problems? Or how medical research is making it easier to predict your genetic risks for disease? 

InTomorrow’s Cure, award-winning journalist Cathy Wurzer facilitates conversations between experts from Mayo Clinic and renowned organizations. Join us as these medical pioneers share their amazing work and how they use innovative thinking in pursuit of answers for patients. What they describe may sound like science fiction, but watch and you will find the future of medicine is already here.

LISTEN NOW:

For people waiting for a lung transplant, every phone call could be life changing. In this episode of Tomorrow’s Cure from Mayo Clinic, host Cathy Wurzer explores how ex vivo lung perfusion, or EVLP, is helping turn a “no” into a “maybe” and sometimes a “yes” for patients who are running out of options. Mayo Clinic cardiothoracic surgeon Dr. Jack Haney and Brandi Zofkie, Associate Vice President at Lung Bioengineering, discuss how EVLP keeps lungs alive outside the body so experts can better evaluate and sometimes improve them before transplant. 

In Season 4 of Tomorrow’s Cure, host Cathy Wurzer interviews physicians, scientists, and medical innovators from Mayo Clinic and other leading institutions to explore breakthroughs in health care, medical research, and patient care. From 3D-printed skin and predictive tools for autoimmune disease to patient-centered AI and lifesaving advancements in organ transplantation, this season brings the future of medicine to the present through real stories and real science.

The skin offers powerful clues about aging and disease. In this episode of Tomorrow’s Cure, host Cathy Wurzer talks with Dr. Saranya Wyles of Mayo Clinic and Dr. Adam Feinberg of Carnegie Mellon University about “SkinSpan” and the fast-evolving field of 3D bioprinted skin. They discuss how living skin models are advancing research on eczema, wounds, burns, and age-related changes, as well as how open‑source bioprinting is making advanced regenerative tools more accessible.

Rheumatoid arthritis is often seen as “just” joint pain, but Mayo Clinic rheumatologist Dr. John Davis and University of Colorado researcher Dr. Kevin Deane reveal a far more complex and promising story. In this episode of Tomorrow’s Cure, the conversation dives into emerging tools that use artificial intelligence to sift through genetics, autoantibodies, microbiome data, and real-world exposures to predict who is most likely to develop rheumatoid arthritis and who will respond to specific treatments.

Cardiovascular disease remains the leading cause of death in the United States, yet new science and smarter systems are changing what is possible for patients and families. In this episode of Tomorrow’s Cure, host Cathy Wurzer talks with three leaders who are reshaping how we prevent, understand, and treat heart disease and obesity. 

For a century, Mayo Clinic Proceedings has captured the evolution of modern medicine, from pioneering cortisone therapy to today’s breakthroughs in artificial intelligence and digital diagnostics. In this episode of Tomorrow’s Cure host, Cathy Wurzer talks with Editor in Chief Dr. Karl Nath and hematologist and longtime contributor Dr. Vincent Rajkumar about the journal’s origins, its global influence, and how it helps physicians turn complex science into practical care.

Automation is quietly reshaping what happens before, during, and after a medical visit, and for many patients it is almost invisible. In this episode of Tomorrow’s Cure, host Cathy Wurzer talks with Mayo Clinic physician leader Dr. Anjali Bhagra and human centered AI expert Dr. Ravi Bapna about how automation and artificial intelligence are changing the way care teams work, how patients access care, and what it takes to keep people at the center of these advances.

Chronic lymphocytic leukemia is the most common leukemia in adults, yet its earliest warning sign often hides in plain sight. Monoclonal B cell lymphocytosis, or MBL, affects millions of adults who may never know they carry this precursor to CLL. In this episode of Tomorrow's Cure from Mayo Clinic, host Cathy Wurzer talks with hematologist Dr. Sameer Parikh and researchers Dr. Susan Slager and Dr. Gerald Marti about how MBL was discovered, what it reveals about inherited risk, and why it matters for infections, second cancers and long term health.

When a child is critically ill and answers are elusive, every day can feel like an eternity. This week on Tomorrow’s Cure from Mayo Clinic, host Cathy Wurzer talks with pediatric geneticist Whitney Thompson, M.D., from Mayo Clinic, genomic medicine pioneer Stephen Kingsmore, M.D., DSc, from Rady Children’s Institute for Genomic Medicine, and Sean George, Ph.D., CEO of Inflection Medicine, about how rapid whole genome sequencing is transforming care for the youngest patients. 

Tomorrow’s Cure is a Mayo Clinic podcast that is bringing the future of healthcare to the present. Listen to engaging discussions with researchers, doctors and industry experts who are at the forefront of medical innovations. Learn how technology and innovation is changing the healthcare landscape, and how previously unavailable solutions are now improving or saving lives. Tomorrow’s Cure inspires deep thinking as we explore our healthcare future together.

Contact Tomorrow’s Cure at tomorrowscure@mayo.edu.

Any use of this site constitutes your agreement to the Terms and Conditions and Privacy Policy below.

Terms and Conditions

Privacy Policy

Notice of Privacy Practices

Notice of Nondiscrimination

A single copy of these materials may be reprinted for noncommercial personal use only. “Mayo,” “Mayo Clinic,” “MayoClinic.org,” “Mayo Clinic Healthy Living,” and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.

© 1998-2025 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved.